title: Multiresidue method for simultaneous determination of ten quinolone antibacterial residues in multimatrix/multispecies animal tissues by liquid chromatography with fluorescence detection: single laboratory validation study.
abstract: Quinolone antibacterials are veterinary drugs authorized for use in food animal production. The analysis of residual amounts of drugs in food from animal origin is important for quality control of products for consumers. For this purpose, Maximum Residue Limits (MRLs) have been set up by a European Union Council Regulation on Veterinary Drug Residues (No. 90/2377/EEC and subsequent), and 8 quinolones received MRLs at concentration levels depending on both the matrix and the animal species of interest. A method was developed for screening and confirming 10 quinolone residues (ciprofloxacin, danofloxacin, difloxacin, enrofloxacin, flumequine, marbofloxacin, nalidixic acid, norfloxacin, oxolinic acid, sarafloxacin) in a wide variety of matrixes of different animal species. It involves extraction of the residues from the biological tissues/fluids by acidic aqueous solution, centrifugation and filtration prior to injection on a C18 narrow-bore column, and detection through a 3-step-mode fluorescence detector. The method was validated during a 2-week study for a set of 8 species-matrixes (i.e., bovine raw milk, bovine muscle, porcine muscle, porcine kidney, porcine liver, fish flesh and skin, poultry muscle, whole egg). Residues were quantified down to 15 microg/kg with limits of detection and quantitation ranging from 4 to 11 and 13 to 36 microg/kg, respectively, which are sufficient compared to the wide range of MRLs set for these substances (from 30 microg/kg for danofloxacin in milk to 1900 microg/kg for difloxacin in poultry liver). The limit of performance of the method in terms of CCalpha and CCbeta, the critical concentrations stated in the Decision No. 2002/657/EC and the ISO Standard No. 11843, has been calculated for the authorized (MRL) substances but only estimated in the case of the nonauthorized (non-MRL) substances.
authors.affiliation: Unité des Résidus de Médicaments Vétérinaires, BP 90203, 35302 Fougères, France. e.verdon@fougeres.afssa.fr
authors.forename: Eric
authors.initials: E
authors.lastname: Verdon
authors.forename: Pierrick
authors.initials: P
authors.lastname: Couedor
authors.forename: Brigitte
authors.initials: B
authors.lastname: Roudaut
authors.forename: Pascal
authors.initials: P
authors.lastname: Sandérs
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000032:analysis*; D002138:Calibration; D002498:Centrifugation; D002845:Chromatography / Q000379:methods; D002853:Chromatography, Liquid; D002939:Ciprofloxacin / Q000031:analogs & derivatives / Q000032:analysis; D004350:Drug Residues; D000077422:Enrofloxacin; D005399:Fishes; D024841:Fluoroquinolones / Q000032:analysis; D005504:Food Analysis; D007668:Kidney / Q000378:metabolism; D008460:Meat; D009268:Nalidixic Acid / Q000032:analysis; D009643:Norfloxacin / Q000032:analysis; D010093:Oxolinic Acid / Q000032:analysis; D015363:Quinolones / Q000032:analysis*; D012015:Reference Standards; D015203:Reproducibility of Results; D013552:Swine; D013997:Time Factors
chemical_list: D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; C068581:danofloxacin; D009268:Nalidixic Acid; D000077422:Enrofloxacin; D002939:Ciprofloxacin; C047225:difloxacin; C080260:marbofloxacin; D010093:Oxolinic Acid; D009643:Norfloxacin; C047224:sarafloxacin; C012976:flumequine